Silco Pharmaceuticals Limited (DSE:SILCOPHL)

Silco Pharmaceuticals Income Statement

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Revenue	431.04	431.54	410.1	464.7	559.47	601.06
Revenue Growth (YoY)	0.31%	5.23%	-11.75%	-16.94%	-6.92%	-18.07%
Cost of Revenue	279.67	278.5	278.25	318.76	372.72	433.3
Gross Profit	151.38	153.04	131.85	145.93	186.75	167.76
Selling, General & Admin	63.68	64.82	62.74	69.74	80.98	80.09
Other Operating Expenses	-0	-0	-0	-0	-0	-0
Operating Expenses	73.64	74.78	72.68	78.75	89.27	88.37
Operating Income	77.73	78.26	59.17	67.18	97.48	79.39
Interest Expense	-0.45	-0.65	-0.93	-0.2	-0.53	-0.76
Interest & Investment Income	0.04	0.04	0.62	0.4	0.32	6.12
Other Non Operating Income (Expenses)	1.32	1.31	1.2	3.3	5.21	4.46
EBT Excluding Unusual Items	78.65	78.96	60.07	70.69	102.48	89.21
Gain (Loss) on Sale of Investments	-0.93	-0.93	-0.72	18.56	6.48	0.42
Pretax Income	77.72	78.03	59.35	89.24	108.96	89.63
Income Tax Expense	35.32	35.38	13.47	20.02	24.51	4.98
Net Income	42.4	42.65	45.88	69.22	84.45	84.65
Net Income to Common	42.4	42.65	45.88	69.22	84.45	84.65
Net Income Growth	-15.07%	-7.04%	-33.72%	-18.03%	-0.23%	1.77%
Shares Outstanding (Basic)	103	104	104	104	104	104
Shares Outstanding (Diluted)	103	104	104	104	104	104
Shares Change (YoY)	-0.30%	-	-	-	-	-
EPS (Basic)	0.41	0.41	0.44	0.67	0.81	0.82
EPS (Diluted)	0.41	0.41	0.44	0.67	0.81	0.82
EPS Growth	-14.82%	-7.04%	-33.72%	-18.03%	-0.23%	1.77%
Free Cash Flow	7.36	7.54	0.05	-1.47	62.95	-119.22
Free Cash Flow Per Share	0.07	0.07	0.00	-0.01	0.61	-1.15
Dividend Per Share	0.110	0.110	0.100	0.300	0.500	1.000
Dividend Growth	10.00%	10.00%	-66.67%	-40.00%	-50.00%	-
Gross Margin	35.12%	35.46%	32.15%	31.40%	33.38%	27.91%
Operating Margin	18.03%	18.14%	14.43%	14.46%	17.42%	13.21%
Profit Margin	9.84%	9.88%	11.19%	14.90%	15.10%	14.08%
Free Cash Flow Margin	1.71%	1.75%	0.01%	-0.32%	11.25%	-19.84%
EBITDA	166.98	167.29	147.77	153.9	172.16	153.98
EBITDA Margin	38.74%	38.77%	36.03%	33.12%	30.77%	25.62%
D&A For EBITDA	89.25	89.03	88.59	86.72	74.68	74.59
EBIT	77.73	78.26	59.17	67.18	97.48	79.39
EBIT Margin	18.03%	18.14%	14.43%	14.46%	17.42%	13.21%
Effective Tax Rate	45.45%	45.35%	22.70%	22.44%	22.49%	5.56%
Advertising Expenses	-	3.45	3.55	3.79	4.84	6.2

Source: S&P Global Market Intelligence. Standard template. Financial Sources.